FIELD: medicine, ophthalmology.
SUBSTANCE: one should perform conjunctival incision and blunt separation of Tenon's capsule up to posterior ocular pole. In area of optic nerve one should perform chemical irritation with 10%-trichloroacetic acid solution and crystalline talc due to introductions in three directions - at positions of 3, 6 and 9 o'clock around optic nerve. Then, additionally, one should introduce about 0.8-1.0 ml suspension of autologous mononuclear cells out of bone marrow into area of patient's optic nerve at the quantity of (15 - 17.5) x 107 alive cells. The suggested innovation improves blood circulation in area of optic nerve and enables to apply one's own restorative body reserve.
EFFECT: higher efficiency of therapy.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DYSTROPHIC DISEASES OF POSTERIOR EYE POLE | 2010 |
|
RU2435556C1 |
| METHOD FOR TREATING THE CASES OF SCLEROTIC RETINAL MACULODYSTROPHY | 2003 |
|
RU2235526C1 |
| METHOD OF TREATING ATROPHY OF OPTIC HERVE | 0 |
|
SU1600765A1 |
| THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
| METHOD OF TREATMENT OF DYSTROPHIC DISEASES OF THE POSTERIOR SECTION OF THE EYE | 0 |
|
SU1391644A1 |
| METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
| METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
| METHOD FOR INTEGRATED PATHOGENETIC TREATMENT OF CENTRAL AND PERIPHERAL TAPETORETINAL DYSTROPHIES WITH APPLYING CELL TECHNOLOGIES | 2011 |
|
RU2467730C2 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2012 |
|
RU2494712C1 |
